Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-02-06T02:01:44.397Z Has data issue: false hasContentIssue false
  • English
  • Français

What is an intention to treat analysis?

Published online by Cambridge University Press:  18 May 2011

Andrea Cipriani  and
Corrado Barbui
Andrea Cipriani*
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona (Italy)
Corrado Barbui
Affiliation:
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona (Italy)
*
Address for correspondence: Dr. A. Cipriani, Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona (Italy). Fax: +39-045-585.871 E-mail: andrea.cipriani@univr.it
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

intention to treatrelative riskrandomisationallocation concealmentstatistics
Type
ABC of Methodology
Information
Epidemiology and Psychiatric Sciences , Volume 17 , Issue 1 , March 2008 , pp. 26 - 27
Copyright
Copyright © Cambridge University Press 2008

References

REFERENCES

Cipriani, A., Nosè, M. & Barbui, C. (2007). What is a risk ratio? Epidemiologia e Psichiatria Sociale 16, 20–21.Google Scholar
Hollis, S. & Campbell, F. (1999). What is meant by intention to treat analysis? Survey of published randomised controlled trials. British Medical Journal 319, 670–674.Google Scholar
Schulz, K.F. & Grimes, D.A. (2002). Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 359, 781–785.CrossRefGoogle ScholarPubMed
Temple, R. & Pledger, G.W. (1980). The FDA's critique of the anturane reinfarction trial. New England Journal of Medicine 303, 1488–1492.Google Scholar